Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Herbal medicine market size to increase by USD 36,636.05 million: Asia to contribute 42% of market growth - Technavio


NEW YORK, Dec. 7, 2022 /PRNewswire/ -- The Herbal Medicine Market by Product, Distribution Channel and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 36,636.05 million at a CAGR of 5.96% between 2022 and 2027. The report provides a comprehensive analysis on growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download A PDF Sample Report

Regional Analysis

By region, the global herbal medicine market is segmented into Asia, North America, Europe, and the Rest of the World (ROW). Asia is estimated to contribute 42% to the growth of the global market over the forecast period. The rise in the demand for ayurvedic products such as extracts, dietary supplements, and personal care products and the increasing number of product launches driving the growth of the regional market.

Company Profiles

The herbal medicine market report includes information on the key products and recent developments of leading vendors, including:

Market Dynamics

The market is driven by factors such as the improved immune system, low side effects, and natural healing properties of herbal medicine. However, inadequate knowledge is hindering market growth.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

Related Reports:

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this herbal medicine market report?

Herbal Medicine Market Scope

Report Coverage

Details

Page number

158

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 5.96%

Market growth 2023-2027

USD 36636.05 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

5.6

Regional analysis

Asia, North America, Europe, and Rest of World (ROW)

Performing market contribution

Asia at 42%

Key countries

US, Germany, UK, China, Japan, and India

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Arizona Natural Products, Arkopharma Laboratories, Beijing Tongrentang Co Ltd., Bio Botanica Inc., Blackmores Ltd., Charak Pharma Pvt. Ltd., Dabur India Ltd., Dasherb Corp., Dr. Willmar Schwabe GmbH and Co. KG, Emami Ltd., Hamdard Laboratories, Himalaya Global Holdings Ltd., Hishimo Pharmaceuticals Pvt. Ltd., Imperial Ginseng Products Ltd., Ricola Group AG, Schaper and Brummer GmbH and Co. KG, Sido Muncul, TSUMURA and Co., Weleda Group, and ZeinPharma Germany GmbH

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product

7 Market Segmentation by Distribution Channel

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 11:05
Parsec Automation Corp. has been recognized by the American Business Awards® ("Stevie Awards®") for its significant contributions to progress in the manufacturing industry and commitment to going above and beyond for its customers. The company was...

at 11:00
IPv4.Global, the world's largest, most-trusted and transparent IPv4 marketplace, today announced it was named the winner of a Silver Stevie® Award in the Fastest Growing Company of the Year - Up to 100 Employees category in The 22nd Annual American...

at 10:52
Today, The Bronx Social Care Network (BSCN), a coalition of Bronx-based federally qualified community health centers (FQHCs) partnering with more than 50 Bronx-based community-based organizations (CBOs), led by Urban Health Plan, one of the largest...

at 10:15
More automation and artificial intelligence integration, improved capabilities for virtual and hybrid events, and an emphasis on data-driven insights and personalisation are what the Event Management Software Market will see in the future....

at 10:12
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...

at 10:05
Gibson, Dunn & Crutcher LLP and Barrasso Usdin Kupperman Freeman & Sarver, LLC announce the filing of a civil rights action on behalf of Tayjha Alfred against Martin Bofill ("Bo") Duhé, the District Attorney for the 16th Judicial District of...



News published on and distributed by: